+
Site Tour

EACTS 2022 Symposium: When can Tendyne TMVR be a relevant substitute for on-pump MVR?

Rudiger Lange’s presentation from a symposium held at EACTS 2022: From established to advanced therapies and technologies that change lives.

Related Videos

AV VALVES 2023: Trending Topics – Timing

AV VALVES 2023:Decision Making in HF – Mitral

EuroEcho 2021: MR Treatment (Evidence)

ESC 2023 Tutorial – TriClip™ | Prof. Donal

EuroEcho 2021: Tricuspid regurgitation: The Evidence

Now you've got Navitor. Remarkable performance.

TAVI Summit - Drive TAVI to the next level

AV VALVES 2023: MR – Mixed MR

TRENDING TOPICS

Amplatzer™ Amulet™ LAA Occluder

Why Amulet™ LAAO: A Case-Based Review with top experts

A. Shah, D. Shah, O.de Backer

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

CONNEXT


HUB
RELATED RESOURCES

ESC 2021: HF & VHD Guidelines

PCR LV 2021: Navitor™ Live-in-a-box

ESC 2022: FMR

PCRLV 2021: Transcatheter mitral valve replacement

CONNEXT


LIVE
RELATED EVENTS

TAVI Summit - Live case from Berlin

TAVI 2023: Calcified valve

TAVI 2023: The next level

AV VALVES 2023: TA, TF in TMVR

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline